Big Pharma, Leadership, and the Startup M&A Outlook
By Monroe Hatch, Senior Director and Pharmaceuticals and Biotech Industry Lead, Integrated Project Management Company, Inc. Will Big Pharma embark on an accelerated buying spree…
Integrated Project Management Company, Inc. (IPM) has expanded its Centers of Excellence (CoEs) to help organizations address specific business challenges and successfully execute on their strategies and programs.
Project management as a discipline has been a critical catalyst among the primary industries that IPM has served over the past 31 years. In today’s environment, growing companies struggle with internal complexity, increased regulatory pressure, competitive threats, and a need to adapt to ever-changing consumer demands. By combining project management with industry and subject matter expertise, IPM helps organizations accelerate strategies and plans and recognize positive business outcomes, sooner.
“Bridging the gap between strategy and execution has always been our passion,” Rich Panico, IPM Founder, President, and Chief Executive Officer, said. “Project management can no longer be viewed as a narrowly defined role in today’s organizations. Rather, we view it as a collaborative partnership that effectively guides the successful execution of strategy to create sustainable value.”
While industries differ, the strategy tied to their initiatives is similar. Through its CoEs, IPM has amalgamated knowledge about specific organizational challenges to elevate the efficacy and value of program and project leadership to create and capture higher value. The CoEs provide subject matter expertise in:
- Mergers and Acquisitions
- Business Technology
- Product Development
- Project Portfolio Management
- Quality and Regulatory
- Change Management
To further drive client value, IPM’s innovation group—Discovery and Development—continually analyzes market trends to discover, design, and develop new approaches and services.
Visit PR Newswire for the complete press release.